About treatment
Toolbox
Photo: N/A
Treatment targets in these patients is almost exclusively directed against the immune response and there are now several treatment alternatives available all with their advantages and disadvantages. Important for a good treatment (stated from our web survey) is:
- According to patients: Quality of life
- According to physicians: protection against long-term disability
- None of these are very well reflected in standard two year randomized clinical trials.
Treatments used in MS
| Generic name | Brand name |
|---|---|
| Interferon beta (IFNβ) | Avonex, Betaferon, Extavia, Rebif, Plegridy |
| Glatiramer acetate (GA) | Copaxone |
| Natalizumab | Tysabri |
| Fingolimod | Gilenya |
| Alemtuzumab | Lemtrada |
| Teriflunomide | Aubagio |
| Dimethylfumarate | Tecfidera |
| Daclizumab | Zinbryta |
| Rituximab | Mabthera |
To find detailed description of mode of actions, doses and side effects, please visit the Medical Products Agency or the Swedish MS society and patient organizations.